GABRIELA ISENIA: Open Payments
NPI 1730736604 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,200 in 100 payments from 22 companies in 2025. Trend: 2023 $1,633 · 2024 $1,746 · 2025 $2,200
Food & beverage: $2,193Education: $7
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $391 |
| GENZYME CORPORATION | 9 | $246 |
| ABBVIE INC. | 17 | $240 |
| Janssen Biotech, Inc. | 4 | $193 |
| UCB, Inc. | 9 | $164 |
| LEO Pharma Inc. | 5 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $104 |
| Genentech USA, Inc. | 3 | $102 |
| Lilly USA, LLC | 5 | $95 |
| Organon LLC | 9 | $91 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, Xolair, TALTZ, ANZUPGO, VTAMA.
Industry payments across AZ — which companies pay providers there.
